HepCBC Mission Statement

HepCBC is a non-profit organization run by and for people infected and affected by hepatitis C. Our mission is to provide education, prevention and support to those living with HCV.

What We Do

The Best of the Week to You: Jan 5 - Jan 12, 2018

Hot Off The Press!

Insulin Resistance in HCV May Be Reversed With DAAs

Hepatitis C (HCV) is associated with insulin resistance, and elimination of the virus may help re-establish glycemic control in affected patients, according to a prospective case-control study published in the Journal of Gastroenterology and Hepatology. Approximately 76.5% of patients who achieved a sustained virologic response experienced improvements in insulin resistance. There was a significant 2.42±1.85 point reduction in insulin resistance as assess

Men who have sex with men urged to get tested for hepatitis A after another outbreak

Why exactly should people in Europe and the US get tested? Since the Europe-wide outbreak began in June 2016, 3,813 cases of hepatitis A have been confirmed, and the European Centre of Disease Control is urging people to get tested. “As of December 18 2017, the monthly number of laboratory-confirmed cases remain significantly higher than in previous years,” the ECDC told The Express. “Although decreasing in its intensity, the outbreak is still ongoi

Hepatitis B Vaccination Low Among HIV-Positive Patients

Patients with HIV are at an increased risk of numerous comorbidities and infections, including hepatitis B virus (HBV). Due to the opioid epidemic, injection drug users have a significantly increased risk of contracting HBV and hepatitis C virus, especially those coinfected with HIV. Recently, the American College of Physicians and CDC released new best practice guidelines to address HBV. The guidelines stress that all adults, including at-risk pregnant w

NASH, HCV cirrhosis predict coronary artery disease in liver transplantation

Patients who underwent liver transplantation evaluation had a high prevalence of coronary artery disease, especially those with nonalcoholic steatohepatitis-related cirrhosis, hepatitis C-related cirrhosis and alcoholic cirrhosis, according to a recently published study. An integral component of the liver transplant evaluation (LTE) is coronary artery disease (CAD) assessment as surgical morbidity and mortality can be as high as 81% and 50%, respectively,